| DrugCentral 2021 supports drug discovery and repositioning S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ... Nucleic acids research 49 (D1), D1160-D1169, 2021 | 160 | 2021 |
| Quantitative estimation of pesticide-likeness for agrochemical discovery S Avram, S Funar-Timofei, A Borota, SR Chennamaneni, AK Manchala, ... Journal of cheminformatics 6, 1-11, 2014 | 82 | 2014 |
| Design, synthesis and pharmaco-toxicological assessment of 5-mercapto-1, 2, 4-triazole derivatives with antibacterial and antiproliferative activity M Mioc, C Soica, V Bercean, S Avram, M Balan‑Porcarasu, D Coricovac, ... International journal of oncology 50 (4), 1175-1183, 2017 | 36 | 2017 |
| DrugCentral 2023 extends human clinical data and integrates veterinary drugs S Avram, TB Wilson, R Curpan, L Halip, A Borota, A Bora, CG Bologa, ... Nucleic acids research 51 (D1), D1276-D1287, 2023 | 25 | 2023 |
| Predictive models for fast and effective profiling of kinase inhibitors A Bora, S Avram, I Ciucanu, M Raica, S Avram Journal of Chemical Information and Modeling 56 (5), 895-905, 2016 | 24 | 2016 |
| Design, Synthesis and Biological Activity Evaluation of S-Substituted 1H-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal Cancer M Mioc, S Avram, V Bercean, L Kurunczi, RM Ghiulai, C Oprean, ... Frontiers in chemistry 6, 373, 2018 | 23 | 2018 |
| Modelling Kinase Inhibition Using Highly Confident Data Sets S Avram, A Bora, L Halip, R Curpan Journal of chemical information and modeling 58 (5), 957-967, 2018 | 20 | 2018 |
| Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors L Crisan, S Avram, L Pacureanu Molecular diversity 21, 385-405, 2017 | 18 | 2017 |
| Exploring the biological promiscuity of high-throughput screening hits through DFT calculations R Curpăn, S Avram, R Vianello, C Bologa Bioorganic & medicinal chemistry 22 (8), 2461-2468, 2014 | 18 | 2014 |
| PLS-DA-docking optimized combined energetic terms (PLSDA-DOCET) protocol: A brief evaluation S Avram, LM Pacureanu, E Seclaman, A Bora, L Kurunczi Journal of chemical information and modeling 51 (12), 3169-3179, 2011 | 18 | 2011 |
| Novel drug targets in 2021. S Avram, L Halip, R Curpan, TI Oprea Nature reviews. Drug Discovery 21 (5), 328-328, 2022 | 17 | 2022 |
| ColBioS-FlavRC: A collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes SI Avram, LM Pacureanu, A Bora, L Crisan, S Avram, L Kurunczi Journal of Chemical Information and Modeling 54 (8), 2360-2370, 2014 | 17 | 2014 |
| QSAR study and molecular docking on indirubin inhibitors of Glycogen Synthase Kinase-3 L Crisan, L Pacureanu, A Bora, S Avram, L Kurunczi, Z Simon Central European Journal of Chemistry 11, 63-77, 2013 | 17 | 2013 |
| Off-patent drug repositioning S Avram, R Curpan, L Halip, A Bora, TI Oprea Journal of chemical information and modeling 60 (12), 5746-5753, 2020 | 16 | 2020 |
| Retrospective group fusion similarity search based on eROCE evaluation metric SI Avram, L Crisan, A Bora, LM Pacureanu, S Avram, L Kurunczi Bioorganic & Medicinal Chemistry 21 (5), 1268-1278, 2013 | 16 | 2013 |
| Novel drug targets in 2019. S Avram, L Halip, R Curpan, TI Oprea Nature Reviews Drug Discovery 19 (5), 300-301, 2020 | 15 | 2020 |
| PLS and shape-based similarity analysis of maleimides–GSK-3 inhibitors L Crisan, L Pacureanu, S Avram, A Bora, S Avram, L Kurunczi Journal of enzyme inhibition and medicinal chemistry 29 (4), 599-610, 2014 | 13 | 2014 |
| Novel drug targets in 2020 S Avram, L Halip, R Curpan, TI Oprea Nature reviews. Drug discovery 20 (5), 333, 2021 | 9 | 2021 |
| Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and molecular docking L Pacureanu, S Avram, A Bora, L Kurunczi, L Crisan Structural Chemistry 30 (3), 911-923, 2019 | 8 | 2019 |
| Docking Study of 3-mercapto-1, 2, 4-triazole Derivatives as Inhibitors for VEGFR and EGFR M Mioc, S Avram, AB Tomescu, DV Chiriac, A Heghes, M Voicu, A Voicu, ... Rev. Chim 68, 500, 2017 | 7 | 2017 |
